Production (Stage)
Nuo Therapeutics, Inc.
AURX
$1.58
-$0.12-7.06%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 21.93% | 26.73% | 28.68% | 25.20% | 17.19% |
| Total Depreciation and Amortization | -5.14% | -8.46% | -7.23% | 1.10% | 13.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -75.51% | -83.57% | 2.08% | 2,364.37% | 4,135.29% |
| Change in Net Operating Assets | 331.55% | 87.74% | -113.05% | -751.74% | -9.85% |
| Cash from Operations | 43.18% | 29.55% | 27.29% | 22.99% | 22.04% |
| Capital Expenditure | -20,157.89% | -2,052.78% | -1,213.56% | 56.20% | 96.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -20,157.89% | -2,052.78% | -1,213.56% | 56.20% | 96.44% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -12.81% | -12.81% | 152.53% | 459.92% | -55.19% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -12.81% | -12.81% | 152.53% | 459.92% | -55.19% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 66.92% | 45.23% | 102.02% | 102.42% | -246.74% |